Thermo Fisher Scientific Inc.
📊 Market Data
📈 Income Statement (SEC Verified)
| Metric | 2024-06 | 2024-09 | 2024-12 | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $10.54B | $10.60B | $42.88B | $10.36B | $10.86B | $11.12B | $44.56B | $11.01B |
| Net Income | $1.55B | $1.63B | $6.33B | $1.51B | $1.62B | $1.62B | $6.70B | $1.65B |
| EPS (Diluted) | $4.04 | $4.25 | $16.53 | $3.98 | $4.28 | $4.27 | $17.74 | $4.43 |
💹 Profitability & Margins
🏦 Balance Sheet
💸 Cash Flow Statement
🎯 Analyst Ratings & Price Targets
Consensus Recommendation
Strong BuyBased on 25 analyst opinions
| Target High | $750.00 |
| Target Mean | $611.56 |
| Target Low | $490.00 |
| Current Price | $442.00 |
| Upside Potential | +38.4% |
🏢 Company Information
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services. The Life Sciences Solutions segment includes reagents, instruments, and consumables for biological and medical research; discovery and production of drugs and vaccines; and diagnosis of infections and diseases. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as ...
| Sector | Healthcare |
| Industry | Life Sciences |
| Employees | 125,000 |
| Headquarters | Waltham, MA, United States |
| Website | https://www.thermofisher.com |
| Exchange | NYQ |
| Currency | USD |
| Shares Outstanding | 371.62M |
| Insider Ownership | 0.2% |
| Institutional Ownership | 94.2% |
| EPS (TTM) | 18.21 |
| EPS (Forward) | 27.30 |
| PEG Ratio | 1.45 |
| Next Earnings Date | 2026-04-23 |